151 related articles for article (PubMed ID: 35245312)
1. Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study.
Taji Heravi A; Henn A; Deuster S; McLennan S; Gloy V; Mitter VR; Briel M;
PLoS One; 2022; 17(3):e0264427. PubMed ID: 35245312
[TBL] [Abstract][Full Text] [Related]
2. Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers.
de Jong AJ; Santa-Ana-Tellez Y; Zuidgeest MGP; Grupstra RJ; Jami F; de Boer A; Gardarsdottir H;
Br J Clin Pharmacol; 2023 Dec; 89(12):3512-3522. PubMed ID: 37438875
[TBL] [Abstract][Full Text] [Related]
3. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
Ito T
PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
[TBL] [Abstract][Full Text] [Related]
4. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT).
Blümle A; Wollmann K; Bischoff K; Kapp P; Lohner S; Nury E; Nitschke K; Zähringer J; Rücker G; Schumacher M
BMC Med Res Methodol; 2021 Aug; 21(1):182. PubMed ID: 34465296
[TBL] [Abstract][Full Text] [Related]
5. Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design.
Nury E; Bischoff K; Wollmann K; Nitschke K; Lohner S; Schumacher M; Rücker G; Blümle A
BMC Med Res Methodol; 2020 Oct; 20(1):246. PubMed ID: 33008297
[TBL] [Abstract][Full Text] [Related]
6. Description and analysis of hospital pharmacies in Madagascar.
Ratsimbazafimahefa HR; Sadeghipour F; Trouiller P; Pannatier A; Allenet B
Ann Pharm Fr; 2018 May; 76(3):218-227. PubMed ID: 29352583
[TBL] [Abstract][Full Text] [Related]
7. Cost-evaluation model for clinical trials in a hospital pharmacy service.
Idoate A; Ortega A; Carrera FJ; Aldaz A; Giráldez J
Pharm World Sci; 1995 Sep; 17(5):172-6. PubMed ID: 8574214
[TBL] [Abstract][Full Text] [Related]
8. The landscape of investigator-initiated oncology trials conducted in mainland China during the past decade (2010-2019).
Cao Y; Ye LM; Fan Z; Yang W; Chen LY; Mei Y; He DY; Mo WJ
Cancer Innov; 2023 Feb; 2(1):79-90. PubMed ID: 38090374
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
10. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
Carroll NV; Rupp MT; Holdford DA
J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
12. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
Ha D; Song I; Lee EK; Shin JY
BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
[TBL] [Abstract][Full Text] [Related]
13. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
14. Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management.
McLennan S; Griessbach A; Briel M;
JAMA Netw Open; 2021 Jun; 4(6):e2111847. PubMed ID: 34076698
[TBL] [Abstract][Full Text] [Related]
15. The Development of Investigator-Initiated Clinical Trials in Surgical Oncology.
McDonald HG; Cassim EB; Harper MM; Burke EE; Marcinkowski EF; Cavnar MJ; Pandalai PK; Kim J
Surg Oncol Clin N Am; 2023 Jan; 32(1):13-25. PubMed ID: 36410913
[TBL] [Abstract][Full Text] [Related]
16. Panoramic quality assessment tool for investigator initiated trials.
Lv W; Hu T; Jiang J; Qu T; Shen E; Duan J; Miao X; Zhang W; Qian B
Front Public Health; 2022; 10():988574. PubMed ID: 36176521
[TBL] [Abstract][Full Text] [Related]
17. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
Carroll NV
J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
[TBL] [Abstract][Full Text] [Related]
18. Managed health care.
Curtiss FR
Am J Hosp Pharm; 1989 Apr; 46(4):742-63. PubMed ID: 2719053
[TBL] [Abstract][Full Text] [Related]
19. Current Status and Challenges of Cancer Clinical Trials in Korea.
Shim BY; Park SH; Lee S; Kim JS; Lee KE; Kang YK; Ahn MJ
Cancer Res Treat; 2016 Jan; 48(1):20-7. PubMed ID: 25761486
[TBL] [Abstract][Full Text] [Related]
20. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
Siu AHY; Krass I; Mitchell B; McNamara K
Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
